CDEK
← All organizations

Shin Nippon Biomedical Laboratories

For profitWebsite ↗

Also known as: Shin Nippon Biomedical Laboratories, Ltd. | SNBL | SNBL, Baltimore,MD 21201 | SNBL Clinical Pharmacology Center | SNBL Clinical Pharmacology Center, Inc. | SNBL Clinical Pharmacology Center Inc, Baltimore, MD | SNBL Pharmacology Center

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Aug 1, 2006

Last known activity

Apr 30, 2025

Timeline

1950s

  1. Jan 1, 1957

    Shin Nippon Biomedical Laboratories— Founded

2020s

  1. Apr 16, 2023

    Satsuma Pharmaceuticals, Inc.— Acquired

Drugs by trial phase (22 distinct, 25 trials)

Phase 3 (0 own, 1 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (21)

  • NCT03076970CollaboratorPhase 1Mar 21, 2017
  • NCT02729207Overall official - principal investigatorPhase 2Jun 1, 2016
  • NCT02486770Overall official - principal investigatorPhase 1Apr 1, 2015
  • NCT02058017CollaboratorPhase 1Nov 1, 2013
  • NCT01925859Overall official - principal investigatorPhase 1Jun 1, 2013
  • NCT01566877Overall official - principal investigatorPhase 1May 1, 2013
  • NCT01609257Overall official - principal investigatorPhase 1/Phase 2Jul 1, 2012
  • NCT01594437Overall official - principal investigatorPhase 1May 1, 2012
  • NCT02018250Overall official - principal investigatorPhase 1Mar 1, 2012
  • NCT01390025Overall official - principal investigatorPhase 1Sep 1, 2011
  • NCT01408394Overall official - principal investigatorPhase 1Aug 1, 2011
  • NCT01088932Overall official - principal investigatorPhase 1Mar 1, 2010
  • NCT00973284Overall official - principal investigatorPhase 1/Phase 2Aug 4, 2009
  • NCT00845650Overall official - principal investigatorPhase 1/Phase 2Feb 1, 2009
  • NCT00805454Overall official - principal investigatorPhase 1Dec 1, 2008

Details

Founded
Tokyo, JP Jan 1, 1957
Last known activity
Apr 30, 2025